K. Nomoto

Yakult Central Institute

Health Outcomes Studied

• Improved Bowel Movement Frequency
• Increased Fecal Bifidobacteria Levels
• Increased Fecal Bifidobacterium Count
• Increased Intestinal Bifidobacteria Levels
• Increased Short-Chain Fatty Acid Levels
• Increased Total Bacterial Count
• Reduced Faecal pH

Papers (8)

• 2019
  Bifidobacterium Supplementation of Colostrum and Breast Milk Enhances Weight Gain and Metabolic Responses Associated with Microbiota Establishment in Very-Preterm Infants10.1159/000502935
• 2016
  Intestinal Microbiota in Pediatric Surgical Cases Administered Bifidobacterium Breve: A Randomized Controlled Trial10.1097/MPG.0000000000001140
• 2015
  The Effectiveness of Lactobacillus Beverages in Controlling Infections among the Residents of an Aged Care Facility: A Randomized Placebo-Controlled Double-Blind Trial10.1159/000442305
• 2014
  A pilot study of Bifidobacterium breve in neonates undergoing surgery for congenital heart disease10.1186/2052-0492-2-36
• 2011
  Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: a randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age.10.1016/j.vaccine.2010.12.133
• 2010
  Effects of a probiotic fermented milk beverage containing Lactobacillus casei strain Shirota on defecation frequency, intestinal microbiota, and the intestinal environment of healthy individuals with soft stools.10.1016/j.jbiosc.2010.05.016
• 2010
  M-RTLV agar, a novel selective medium to distinguish Lactobacillus casei and Lactobacillus paracasei from Lactobacillus rhamnosus.10.1016/j.ijfoodmicro.2010.03.019
• 2004
  Probiotic Bifidobacteria Protect Mice from Lethal Infection with Shiga Toxin-Producing Escherichia coli O157:H710.1128/IAI.72.4.2240-2247.2004